• Intangible assets increased by $10.8m due to retrospective restatement of valuation
• $125m of debt reclassified from non-current to current borrowings
• $57.1m expected credit loss allowance for retail pharmacy group receivables

Paragon Care Limited (ASX:PGC), a leading healthcare wholesaler, distributor, and manufacturer throughout the Asia Pacific region, has released its annual report for the ParagonCare Group ('Group') including the audited financial statements for the full year ended 30 June 2025 ('FY25'). The key changes between the Appendix 4E Preliminary final report and the final audited financial statements include: 1) An increase in Other Comprehensive Income of $10.8m with a corresponding increase in Intangible Assets across Goodwill ($3.7m), Supplier Contracts ($6.6m) and Brands ($0.3m) due to the retrospective restatement of the valuation of intangible assets attributed to the reverse acquisition of ParagonCare. 2) A $125 million increase in Current Borrowings with a corresponding decrease to Non-Current Borrowings due to the Directors exercising judgement to classify a portion of the debt as current, despite the Company maintaining access to the minimum drawdown amount for more than 12 months. 3) The Company acknowledges the qualification expressed by its auditor, EY, regarding the expected credit loss (ECL) allowance for trade and other receivables associated with a retail pharmacy group of $57,130,000 as at 30 June 2025. The Company continues to explore growth opportunities both organically and inorganically, with a good acquisition pipeline in place, with particular emphasis on Asia.

The Company continues to explore growth opportunities both organically, with continued expansion into new businesses, and inorganically, with a good acquisition pipeline in place, with particular emphasis on Asia.